OpenURL Connection Search

Select item for more details and to access through your institution.

Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
Published in:
Angewandte Chemie, 2019, v. 131, n. 15, p. 53, doi. 10.1111/bjh.15768
By:
- Rosenbaum, Cara A.;
- Jung, Sin‐Ho;
- Pitcher, Brandelyn;
- Bartlett, Nancy L.;
- Smith, Sonali M.;
- Hsi, Eric;
- Wagner‐Johnston, Nina;
- Thomas, Sachdev P.;
- Leonard, John P.;
- Cheson, Bruce D.
Publication type:
Article
Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
Published in:
British Journal of Haematology, 2019, v. 185, n. 1, p. 53, doi. 10.1111/bjh.15768
By:
- Rosenbaum, Cara A.;
- Jung, Sin‐Ho;
- Pitcher, Brandelyn;
- Bartlett, Nancy L.;
- Smith, Sonali M.;
- Hsi, Eric;
- Wagner‐Johnston, Nina;
- Thomas, Sachdev P.;
- Leonard, John P.;
- Cheson, Bruce D.
Publication type:
Article
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).
Published in:
2017
By:
- Kimmick, Gretchen;
- Major, Brittny;
- Clapp, Jonathan;
- Sloan, Jeff;
- Pitcher, Brandelyn;
- Ballman, Karla;
- Barginear, Myra;
- Freedman, Rachel;
- Artz, Andrew;
- Klepin, Heidi;
- Lafky, Jacqueline;
- Hopkins, Judith;
- Winer, Eric;
- Hudis, Clifford;
- Muss, Hyman;
- Cohen, Harvey;
- Jatoi, Aminah;
- Hurria, Arti;
- Mandelblatt, Jeanne
Publication type:
Report
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
Published in:
2013
By:
- Freedman, Rachel;
- Pitcher, Brandelyn;
- Keating, Nancy;
- Ballman, Karla;
- Mandelblatt, Jeanne;
- Kornblith, Alice;
- Kimmick, Gretchen;
- Hurria, Arti;
- Winer, Eric;
- Hudis, Clifford;
- Cohen, Harvey;
- Muss, Hyman
Publication type:
Report
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
Published in:
Breast Cancer Research & Treatment, 2013, v. 138, n. 2, p. 457, doi. 10.1007/s10549-013-2416-2
By:
- Martín, Miguel;
- Prat, Aleix;
- Rodríguez-Lescure, Álvaro;
- Caballero, Rosalía;
- Ebbert, Mark;
- Munárriz, Blanca;
- Ruiz-Borrego, Manuel;
- Bastien, Roy;
- Crespo, Carmen;
- Davis, Carole;
- Rodríguez, César;
- López-Vega, José;
- Furió, Vicente;
- García, Ana;
- Casas, Maribel;
- Ellis, Matthew;
- Berry, Donald;
- Pitcher, Brandelyn;
- Harris, Lyndsay;
- Ruiz, Amparo
Publication type:
Article
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.
Published in:
Cancer Medicine, 2019, v. 8, n. 1, p. 165, doi. 10.1002/cam4.1918
By:
- Lansigan, Frederick;
- Barak, Ian;
- Pitcher, Brandelyn;
- Jung, Sin‐Ho;
- Cheson, Bruce D.;
- Czuczman, Myron;
- Martin, Peter;
- Hsi, Eric;
- Schöder, Heiko;
- Smith, Scott;
- Bartlett, Nancy L.;
- Leonard, John P.;
- Blum, Kristie A.
Publication type:
Article
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).
Published in:
2016
By:
- Mandelblatt, Jeanne S.;
- Clapp, Jonathan D.;
- Luta, Gheorghe;
- Faul, Leigh Anne;
- Tallarico, Michelle D.;
- McClendon, Trina D.;
- Whitley, Jessica A.;
- Cai, Ling;
- Ahles, Tim A.;
- Stern, Robert A.;
- Jacobsen, Paul B.;
- Small, Brent J.;
- Pitcher, Brandelyn N.;
- Dura-Fernandis, Estrella;
- Muss, Hyman B.;
- Hurria, Arti;
- Cohen, Harvey J.;
- Isaacs, Claudine
Publication type:
journal article

Found: 7

Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).

Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.

Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).